ESG28 Sept 2026, 06:30 pm
Gufic Biosciences Gets Independent ESG Rating of 'Strong'
AI Summary
Gufic Biosciences Ltd has received an independent ESG rating of CRISIL ESG 62 (Category: Strong) for FY 2025-26 from Crisil ESG Ratings & Analytics Ltd. The rating was assigned based on publicly available information for the fiscal year and the company did not engage Crisil for this assessment. This independent evaluation highlights the company's environmental, social, and governance performance.
Key Highlights
- Gufic Biosciences received an ESG rating of CRISIL ESG 62.
- The rating category assigned is 'Strong'.
- The rating is for the Financial Year 2025-26.
- Crisil assigned the rating independently.
- The company did not engage Crisil for this rating.
Price Impact
More from GUFICBIO